Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank check company formed to pursue a business combination in the healthcare and medical technology sector, with a stated focus on companies leveraging data-driven and technology-enabled approaches to improve medical outcomes. The SPAC completed its initial public offering in 2022 and filed an 8-K with the Securities and Exchange Commission on February 9, 2023, under accession number 0001104659-23-017381. As of that filing date, the company remained in the search phase, seeking a qualifying acquisition target within its defined healthcare technology mandate. Visitors seeking the full filing history, deal timeline, and institutional holder data for IQMD can access comprehensive coverage by signing up for a free account at SpacDesk.